Endothelin-1 and monocyte chemoattractant protein-1 modulation in ischemia and human brain-derived endothelial cell cultures

被引:57
作者
Chen, P
Shibata, M
Zidovetzki, R
Fisher, M
Zlokovic, BV
Hofman, FM
机构
[1] Univ So Calif, Sch Med, Dept Pathol, Los Angeles, CA 90033 USA
[2] Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA
[3] Univ Calif Irvine, Dept Neurol, Irvine, CA 92868 USA
[4] Univ Rochester, Sch Med, Inst Biomed Sci, Ctr Aging & Dev Biol,Div Neurovasc Biol, Rochester, NY 14642 USA
关键词
endothelin; MCP-1; cerebral ischemia; macrophage; endothelium;
D O I
10.1016/S0165-5728(01)00280-6
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Brain tissue damage due to ischemia/reperfusion has been shown to be caused, in part, by activated macrophages infiltrating into the post-ischemic brain. Using the Middle Cerebral Artery Occlusion (MCAO) mouse model, this study demonstrated that, in vivo, bath endothelin-1 (Et-1), a potent vasoconstrictor, and the macrophage chemokine, monocyte chemoattractant factor-1 (MCP-1) are induced in ischemia. Further studies, using human brain-derived endothelial cells (CNS-EC), showed that in vitro, Et-1 can directly stimulate MCP-1 mRNA expression and MCP-1 protein; and this Et-1-induced MCP-1 production is mediated by the ETA receptor. Inflammatory cytokines, tumor necrosis factor alpha and interleukin-1 beta, functioned additively and synergistically, respectively, with Et-1 to increase this MCP-1 production. Partial elucidation of the signal transduction pathways involved in Et-1-induced MCP-1 production demonstrated that protein kinase C-, but not cAMP-dependent pathways are involved. These data demonstrate that Et-1 functioning as an inflammatory peptide, increased levels of MCP-1, suggesting a mechanism for chemokine regulation during ischemia/reperfusion injury. (C) 2001 Published by Elsevier Science B.V.
引用
收藏
页码:62 / 73
页数:12
相关论文
共 62 条
  • [1] BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97
  • [2] BARONE FC, 1995, J CARDIOVASC PHARM, V26, pS404
  • [3] ENDOTHELIN LEVELS INCREASE IN RAT FOCAL AND GLOBAL-ISCHEMIA
    BARONE, FC
    GLOBUS, MYT
    PRICE, WJ
    WHITE, RF
    STORER, BL
    FEUERSTEIN, GZ
    BUSTO, R
    OHLSTEIN, EH
    [J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1994, 14 (02) : 337 - 342
  • [4] Endothelin receptor antagonist preserves microvascular perfusion and reduces ischemic brain damage following permanent focal ischemia
    Dawson, DA
    Sugano, H
    McCarron, RM
    Hallenbeck, JM
    Spatz, M
    [J]. NEUROCHEMICAL RESEARCH, 1999, 24 (12) : 1499 - 1505
  • [5] HIGH PLASMA-LEVELS OF ENDOTHELIN-1 AND ATRIAL-NATRIURETIC-PEPTIDE IN PATIENTS WITH ACUTE ISCHEMIC STROKE
    ESTRADA, V
    TELLEZ, MJ
    MOYA, J
    FERNANDEZDURANGO, R
    EGIDO, J
    CRUZ, AF
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 1994, 7 (12) : 1085 - 1089
  • [6] Endothelial cell responses to hypoxic stress
    Faller, DV
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1999, 26 (01) : 74 - 84
  • [7] PEPTIDIC ENDOTHELIN-1 RECEPTOR ANTAGONIST, BQ-123, AND NEUROPROTECTION
    FEUERSTEIN, G
    GU, JL
    OHLSTEIN, EH
    BARONE, FC
    YUE, TL
    [J]. PEPTIDES, 1994, 15 (03) : 467 - 469
  • [8] FEUERSTEIN GZ, 1994, CEREBROVAS BRAIN MET, V6, P341
  • [9] FLORY CM, 1993, LAB INVEST, V69, P396
  • [10] FURIE MB, 1995, AM J PATHOL, V146, P1287